Speech acoustic markers of early stage and prodromal Huntington's disease: A marker of disease onset?

Speech disturbances (e.g., altered prosody) have been described in symptomatic Huntington's Disease (HD) individuals, however, the extent to which speech changes in gene positive pre-manifest (PreHD) individuals is largely unknown. The speech of individuals carrying the mutant HTT gene is a beh...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neuropsychologia 2012-12, Vol.50 (14), p.3273-3278
Hauptverfasser: Vogel, Adam P., Shirbin, Christopher, Churchyard, Andrew J., Stout, Julie C.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 3278
container_issue 14
container_start_page 3273
container_title Neuropsychologia
container_volume 50
creator Vogel, Adam P.
Shirbin, Christopher
Churchyard, Andrew J.
Stout, Julie C.
description Speech disturbances (e.g., altered prosody) have been described in symptomatic Huntington's Disease (HD) individuals, however, the extent to which speech changes in gene positive pre-manifest (PreHD) individuals is largely unknown. The speech of individuals carrying the mutant HTT gene is a behavioural/motor/cognitive marker demonstrating some potential as an objective indicator of early HD onset and disease progression. Speech samples were acquired from 30 individuals carrying the mutant HTT gene (13 PreHD, 17 early stage HD) and 15 matched controls. Participants read a passage, produced a monologue and said the days of the week. Data were analysed acoustically for measures of timing, frequency and intensity. There was a clear effect of group across most acoustic measures, so that speech performance differed in-line with disease progression. Comparisons across groups revealed significant differences between the control and the early stage HD group on measures of timing (e.g., speech rate). Participants carrying the mutant HTT gene presented with slower rates of speech, took longer to say words and produced greater silences between and within words compared to healthy controls. Importantly, speech rate showed a significant correlation to burden of disease scores. The speech of early stage HD differed significantly from controls. The speech of PreHD, although not reaching significance, tended to lie between the performance of controls and early stage HD. This suggests that changes in speech production appear to be developing prior to diagnosis. ► Speech production can be considered a marker of central nervous system integrity. ► Psychomotor changes occur in individual's with Huntington's disease before diagnosis. ► Speech performance differs in-line with disease state. ► Speech rate shows a significant correlation to burden of pathology scores. ► Data suggests that changes in speech production are developing prior to diagnosis.
doi_str_mv 10.1016/j.neuropsychologia.2012.09.011
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1449083365</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0028393212003831</els_id><sourcerecordid>1427001631</sourcerecordid><originalsourceid>FETCH-LOGICAL-c458t-3b8b6a242d3174ba9a89cb2f3997018c03a3274367bb48028a030a92cc50ff663</originalsourceid><addsrcrecordid>eNqNkUtv1DAUha2qqJ22_AXkFWWTcP1IYrNoVVWUQarEgrK2HOdm6iETT-0Eaf49Hs3Agg1dXenqO_dxDiHvGZQMWP1xXY44x7BNO_cchrDytuTAeAm6BMZOyIKpRhSiYvKULAC4KoQW_JxcpLQGAFlxdUbOOdeK11AvCH7fIrpnal2Y0-Qd3dj4E2Oioado47CjabIrpHbs6DaGLoaNHehyHic_rqYwXifa-YQ24Sd6dxTvtccmDWPC6faKvOntkPDtsV6SHw-fn-6XxeO3L1_v7x4LJys1FaJVbW255J1gjWyttkq7lvdC6waYciCs4I0UddO2UuXnLAiwmjtXQd_XtbgkHw5z86kvM6bJbHxyOAx2xPyfYVJqUELU1StQ3kB2XLD_o1w0FUjGdEZvDqiLIaWIvdlGn13ZGQZmH6BZm38DNPsADWiTA8wD3h13ze0Gu7_yP4llYHkAMPv4y2M0yXkcHXY-optMF_xrd_0GraG2Bg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1237504119</pqid></control><display><type>article</type><title>Speech acoustic markers of early stage and prodromal Huntington's disease: A marker of disease onset?</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Vogel, Adam P. ; Shirbin, Christopher ; Churchyard, Andrew J. ; Stout, Julie C.</creator><creatorcontrib>Vogel, Adam P. ; Shirbin, Christopher ; Churchyard, Andrew J. ; Stout, Julie C.</creatorcontrib><description>Speech disturbances (e.g., altered prosody) have been described in symptomatic Huntington's Disease (HD) individuals, however, the extent to which speech changes in gene positive pre-manifest (PreHD) individuals is largely unknown. The speech of individuals carrying the mutant HTT gene is a behavioural/motor/cognitive marker demonstrating some potential as an objective indicator of early HD onset and disease progression. Speech samples were acquired from 30 individuals carrying the mutant HTT gene (13 PreHD, 17 early stage HD) and 15 matched controls. Participants read a passage, produced a monologue and said the days of the week. Data were analysed acoustically for measures of timing, frequency and intensity. There was a clear effect of group across most acoustic measures, so that speech performance differed in-line with disease progression. Comparisons across groups revealed significant differences between the control and the early stage HD group on measures of timing (e.g., speech rate). Participants carrying the mutant HTT gene presented with slower rates of speech, took longer to say words and produced greater silences between and within words compared to healthy controls. Importantly, speech rate showed a significant correlation to burden of disease scores. The speech of early stage HD differed significantly from controls. The speech of PreHD, although not reaching significance, tended to lie between the performance of controls and early stage HD. This suggests that changes in speech production appear to be developing prior to diagnosis. ► Speech production can be considered a marker of central nervous system integrity. ► Psychomotor changes occur in individual's with Huntington's disease before diagnosis. ► Speech performance differs in-line with disease state. ► Speech rate shows a significant correlation to burden of pathology scores. ► Data suggests that changes in speech production are developing prior to diagnosis.</description><identifier>ISSN: 0028-3932</identifier><identifier>EISSN: 1873-3514</identifier><identifier>DOI: 10.1016/j.neuropsychologia.2012.09.011</identifier><identifier>PMID: 22982606</identifier><identifier>CODEN: NUPSA6</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Adult ; Aged ; Biomarkers ; Case-Control Studies ; Clinical marker ; Disease Progression ; Female ; Humans ; Huntingtin Protein ; Huntington Disease - diagnosis ; Huntington Disease - genetics ; Huntington Disease - physiopathology ; Huntington's disease ; Male ; Middle Aged ; Nerve Tissue Proteins - genetics ; Neuropsychological Tests ; Prodomal ; Reaction Time - physiology ; Speech ; Speech - physiology ; Speech Acoustics ; Time Factors</subject><ispartof>Neuropsychologia, 2012-12, Vol.50 (14), p.3273-3278</ispartof><rights>2012 Elsevier Ltd</rights><rights>Copyright © 2012 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c458t-3b8b6a242d3174ba9a89cb2f3997018c03a3274367bb48028a030a92cc50ff663</citedby><cites>FETCH-LOGICAL-c458t-3b8b6a242d3174ba9a89cb2f3997018c03a3274367bb48028a030a92cc50ff663</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.neuropsychologia.2012.09.011$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3536,27903,27904,45974</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22982606$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Vogel, Adam P.</creatorcontrib><creatorcontrib>Shirbin, Christopher</creatorcontrib><creatorcontrib>Churchyard, Andrew J.</creatorcontrib><creatorcontrib>Stout, Julie C.</creatorcontrib><title>Speech acoustic markers of early stage and prodromal Huntington's disease: A marker of disease onset?</title><title>Neuropsychologia</title><addtitle>Neuropsychologia</addtitle><description>Speech disturbances (e.g., altered prosody) have been described in symptomatic Huntington's Disease (HD) individuals, however, the extent to which speech changes in gene positive pre-manifest (PreHD) individuals is largely unknown. The speech of individuals carrying the mutant HTT gene is a behavioural/motor/cognitive marker demonstrating some potential as an objective indicator of early HD onset and disease progression. Speech samples were acquired from 30 individuals carrying the mutant HTT gene (13 PreHD, 17 early stage HD) and 15 matched controls. Participants read a passage, produced a monologue and said the days of the week. Data were analysed acoustically for measures of timing, frequency and intensity. There was a clear effect of group across most acoustic measures, so that speech performance differed in-line with disease progression. Comparisons across groups revealed significant differences between the control and the early stage HD group on measures of timing (e.g., speech rate). Participants carrying the mutant HTT gene presented with slower rates of speech, took longer to say words and produced greater silences between and within words compared to healthy controls. Importantly, speech rate showed a significant correlation to burden of disease scores. The speech of early stage HD differed significantly from controls. The speech of PreHD, although not reaching significance, tended to lie between the performance of controls and early stage HD. This suggests that changes in speech production appear to be developing prior to diagnosis. ► Speech production can be considered a marker of central nervous system integrity. ► Psychomotor changes occur in individual's with Huntington's disease before diagnosis. ► Speech performance differs in-line with disease state. ► Speech rate shows a significant correlation to burden of pathology scores. ► Data suggests that changes in speech production are developing prior to diagnosis.</description><subject>Adult</subject><subject>Aged</subject><subject>Biomarkers</subject><subject>Case-Control Studies</subject><subject>Clinical marker</subject><subject>Disease Progression</subject><subject>Female</subject><subject>Humans</subject><subject>Huntingtin Protein</subject><subject>Huntington Disease - diagnosis</subject><subject>Huntington Disease - genetics</subject><subject>Huntington Disease - physiopathology</subject><subject>Huntington's disease</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Nerve Tissue Proteins - genetics</subject><subject>Neuropsychological Tests</subject><subject>Prodomal</subject><subject>Reaction Time - physiology</subject><subject>Speech</subject><subject>Speech - physiology</subject><subject>Speech Acoustics</subject><subject>Time Factors</subject><issn>0028-3932</issn><issn>1873-3514</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkUtv1DAUha2qqJ22_AXkFWWTcP1IYrNoVVWUQarEgrK2HOdm6iETT-0Eaf49Hs3Agg1dXenqO_dxDiHvGZQMWP1xXY44x7BNO_cchrDytuTAeAm6BMZOyIKpRhSiYvKULAC4KoQW_JxcpLQGAFlxdUbOOdeK11AvCH7fIrpnal2Y0-Qd3dj4E2Oioado47CjabIrpHbs6DaGLoaNHehyHic_rqYwXifa-YQ24Sd6dxTvtccmDWPC6faKvOntkPDtsV6SHw-fn-6XxeO3L1_v7x4LJys1FaJVbW255J1gjWyttkq7lvdC6waYciCs4I0UddO2UuXnLAiwmjtXQd_XtbgkHw5z86kvM6bJbHxyOAx2xPyfYVJqUELU1StQ3kB2XLD_o1w0FUjGdEZvDqiLIaWIvdlGn13ZGQZmH6BZm38DNPsADWiTA8wD3h13ze0Gu7_yP4llYHkAMPv4y2M0yXkcHXY-optMF_xrd_0GraG2Bg</recordid><startdate>201212</startdate><enddate>201212</enddate><creator>Vogel, Adam P.</creator><creator>Shirbin, Christopher</creator><creator>Churchyard, Andrew J.</creator><creator>Stout, Julie C.</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7TK</scope><scope>7T9</scope></search><sort><creationdate>201212</creationdate><title>Speech acoustic markers of early stage and prodromal Huntington's disease: A marker of disease onset?</title><author>Vogel, Adam P. ; Shirbin, Christopher ; Churchyard, Andrew J. ; Stout, Julie C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c458t-3b8b6a242d3174ba9a89cb2f3997018c03a3274367bb48028a030a92cc50ff663</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Biomarkers</topic><topic>Case-Control Studies</topic><topic>Clinical marker</topic><topic>Disease Progression</topic><topic>Female</topic><topic>Humans</topic><topic>Huntingtin Protein</topic><topic>Huntington Disease - diagnosis</topic><topic>Huntington Disease - genetics</topic><topic>Huntington Disease - physiopathology</topic><topic>Huntington's disease</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Nerve Tissue Proteins - genetics</topic><topic>Neuropsychological Tests</topic><topic>Prodomal</topic><topic>Reaction Time - physiology</topic><topic>Speech</topic><topic>Speech - physiology</topic><topic>Speech Acoustics</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Vogel, Adam P.</creatorcontrib><creatorcontrib>Shirbin, Christopher</creatorcontrib><creatorcontrib>Churchyard, Andrew J.</creatorcontrib><creatorcontrib>Stout, Julie C.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Neurosciences Abstracts</collection><collection>Linguistics and Language Behavior Abstracts (LLBA)</collection><jtitle>Neuropsychologia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Vogel, Adam P.</au><au>Shirbin, Christopher</au><au>Churchyard, Andrew J.</au><au>Stout, Julie C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Speech acoustic markers of early stage and prodromal Huntington's disease: A marker of disease onset?</atitle><jtitle>Neuropsychologia</jtitle><addtitle>Neuropsychologia</addtitle><date>2012-12</date><risdate>2012</risdate><volume>50</volume><issue>14</issue><spage>3273</spage><epage>3278</epage><pages>3273-3278</pages><issn>0028-3932</issn><eissn>1873-3514</eissn><coden>NUPSA6</coden><abstract>Speech disturbances (e.g., altered prosody) have been described in symptomatic Huntington's Disease (HD) individuals, however, the extent to which speech changes in gene positive pre-manifest (PreHD) individuals is largely unknown. The speech of individuals carrying the mutant HTT gene is a behavioural/motor/cognitive marker demonstrating some potential as an objective indicator of early HD onset and disease progression. Speech samples were acquired from 30 individuals carrying the mutant HTT gene (13 PreHD, 17 early stage HD) and 15 matched controls. Participants read a passage, produced a monologue and said the days of the week. Data were analysed acoustically for measures of timing, frequency and intensity. There was a clear effect of group across most acoustic measures, so that speech performance differed in-line with disease progression. Comparisons across groups revealed significant differences between the control and the early stage HD group on measures of timing (e.g., speech rate). Participants carrying the mutant HTT gene presented with slower rates of speech, took longer to say words and produced greater silences between and within words compared to healthy controls. Importantly, speech rate showed a significant correlation to burden of disease scores. The speech of early stage HD differed significantly from controls. The speech of PreHD, although not reaching significance, tended to lie between the performance of controls and early stage HD. This suggests that changes in speech production appear to be developing prior to diagnosis. ► Speech production can be considered a marker of central nervous system integrity. ► Psychomotor changes occur in individual's with Huntington's disease before diagnosis. ► Speech performance differs in-line with disease state. ► Speech rate shows a significant correlation to burden of pathology scores. ► Data suggests that changes in speech production are developing prior to diagnosis.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>22982606</pmid><doi>10.1016/j.neuropsychologia.2012.09.011</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0028-3932
ispartof Neuropsychologia, 2012-12, Vol.50 (14), p.3273-3278
issn 0028-3932
1873-3514
language eng
recordid cdi_proquest_miscellaneous_1449083365
source MEDLINE; Elsevier ScienceDirect Journals
subjects Adult
Aged
Biomarkers
Case-Control Studies
Clinical marker
Disease Progression
Female
Humans
Huntingtin Protein
Huntington Disease - diagnosis
Huntington Disease - genetics
Huntington Disease - physiopathology
Huntington's disease
Male
Middle Aged
Nerve Tissue Proteins - genetics
Neuropsychological Tests
Prodomal
Reaction Time - physiology
Speech
Speech - physiology
Speech Acoustics
Time Factors
title Speech acoustic markers of early stage and prodromal Huntington's disease: A marker of disease onset?
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T04%3A12%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Speech%20acoustic%20markers%20of%20early%20stage%20and%20prodromal%20Huntington's%20disease:%20A%20marker%20of%20disease%20onset?&rft.jtitle=Neuropsychologia&rft.au=Vogel,%20Adam%20P.&rft.date=2012-12&rft.volume=50&rft.issue=14&rft.spage=3273&rft.epage=3278&rft.pages=3273-3278&rft.issn=0028-3932&rft.eissn=1873-3514&rft.coden=NUPSA6&rft_id=info:doi/10.1016/j.neuropsychologia.2012.09.011&rft_dat=%3Cproquest_cross%3E1427001631%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1237504119&rft_id=info:pmid/22982606&rft_els_id=S0028393212003831&rfr_iscdi=true